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Background: The recent emergence of a novel coronavirus in the Middle East (designated MERS-CoV) is a reminder
of the zoonotic and pathogenic potential of emerging coronaviruses in humans. Clinical features of Middle East
respiratory syndrome (MERS) include atypical pneumonia and progressive respiratory failure that is highly reminiscent
of severe acute respiratory syndrome (SARS) caused by SARS-CoV. The host response is a key component of highly
pathogenic respiratory virus infection. Here, we computationally analyzed gene expression changes in a human
airway epithelial cell line infected with two genetically distinct MERS-CoV strains obtained from human patients,
MERS-CoV SA 1 and MERS-CoV Eng 1.
Results: Using topological techniques, including persistence homology and filtered clustering, we performed a
comparative transcriptional analysis of human Calu-3 cell host responses to the different MERS-CoV strains, with
MERS-CoV Eng 1 inducing early kinetic changes, between 3 and 12 hours post infection, compared to MERS-CoV
SA 1. Robust transcriptional changes distinguished the two MERS-CoV strains predominantly at the late time points.
Combining statistical analysis of infection and cytokine-stimulated Calu-3 transcriptomics, we identified differential
innate responses, including up-regulation of extracellular remodeling genes following MERS-CoV Eng 1 infection
and differential pro-inflammatory responses.
Conclusions: Through our genomics-based approach, we found topological differences in the kinetics and magnitude
of the host response to MERS-CoV SA 1 and MERS-CoV Eng 1, with differential expression of innate immune and
pro-inflammatory responsive genes as a result of IFN, TNF and IL-1α signaling. Predicted activation for STAT3 mediating
gene expression relevant for epithelial cell-to-cell adherens and junction signaling in MERS-CoV Eng 1 infection suggest
that these transcriptional differences may be the result of amino acid differences in viral proteins known to modulate
innate immunity during MERS-CoV infection.
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Middle East respiratory syndrome coronavirus (MERS-
CoV) is the etiologic agent of an ongoing respiratory
disease outbreak that emerged in Saudi Arabia in 2012.
MERS-CoV is most closely related to Tylonycteris bat
coronavirus HKU4 and Pipistrellus bat coronavirus
HKU5 [1], highlighting the ever present threat of zoonotic
transmission of novel pathogenic coronaviruses. Middle
East respiratory syndrome (MERS) resembles acute
respiratory disease syndrome (ARDS) caused by severe acute
respiratory disease syndrome coronavirus (SARS-CoV)
in 2002 and 2003, with some MERS patients exhibiting
progressive respiratory distress and renal failure [1,2].
Despite similarities in overt clinical disease, MERS-CoV is
distinct from SARS-CoV in that the virus utilizes a differ-
ent cellular receptor, dipeptidyl peptidase-4 (DPP4) [3],
and exhibits an expanded host cell tropism, readily rep-
licating in a variety of human lung cell types including
fibroblasts, microvascular endothelial cells, and type II
pneumocytes [4].
Innate immune and pro-inflammatory responses to
MERS-CoV remains poorly understood. Human cell cul-
ture models of MERS infection have shown a deficiency in
interferon (IFN) induction and innate immune responses,
which may in part result from multiple mechanisms
of MERS-CoV regulation of host antiviral responses. In
addition to accessory protein 4a (p4a), the MERS-CoV
viral papain-like protease (PLpro) can also block IFN-β
induction, as well as downregulate expression of CCL5
and CXCL10 pro-inflammatory cytokine genes [5,6]. Siu
and colleagues showed that the block in IFN production
is in part the result of MERS-CoV p4a interaction with
cellular dsRNA-binding protein PACT that interferes
with the activation of RIG-I-like receptors RIG-I and
MDA5 [7]. In A549 lung epithelial cells and human
bronchus and lung tissue ex vivo cultures, MERS-CoV
SA 1 failed to induce significant expression differences
of IFNB1 and TNF genes relative to mock throughout
the 72 hour infection course [8]. The delay of IFN-β
expression in response to MERS-CoV was also observed
in Calu-3 airway cells [9]. In a separate study, the
expression of a panel of interferon-responsive genes,
including DDX58 (encoding RIG-I), IL1B, and CXCL10,
was undetectable in human airway epithelial (HAE) cultures
infected with MERS-CoV SA 1, despite efficient viral
replication [10]. However, pre-treatment of HAE cells
with recombinant IFN-α or IFN-λ suppressed MERS-
CoV SA 1 replication, indicating viral sensitivity to
innate immune responses [10].
A functional genomics approach revealed MERS-CoV
and infectious clone SARS-CoV (icSARS-CoV) activated
expression of pathogen recognition receptor genes and
pro-inflammatory cytokine genes related to interleukin
17 (IL-17) signaling by IL-17A and IL-17 F cytokines, whiledifferentially regulating antigen presentation pathway
gene expression [11]. The human immune response to
MERS-CoV appears to be distinct across patients, with
increased secretion of IL-17A and IL-23 in bronchoal-
veolar lavage (BAL) supernatants and increased CXCL10
in serum of patients infected with MERS-CoV [12]. The pa-
tient with the poor outcome showed decreased expression
of innate immune genes, such as DDX58, IFIH1 (encoding
MDA5), IRF3, IRF7, IFNA, and IFNB1, which may be the
result of host and virus-specific genetic differences. Recent
phylogenetic analyses of the complete viral genome from
21 different MERS cases demonstrate the extent of adaptive
changes in MERS-CoV since the initial outbreak [13].
To further investigate MERS-CoV regulation of innate
immune and pro-inflammatory responses, we utilized an
established human airway culture system to examine
cellular responses against two genetically distinct MERS-
CoV strains, a primary isolate obtained from a Qatari
patient treated at a London hospital in September 2012
who later died after prolonged illness in June 2013
(herein referred to as MERS-CoV Eng 1) [2] and MERS-
CoV SA 1 (herein referred to as MERS-CoV SA 1), the
first virus identified from a fatal case in Saudi Arabia in
June 2012 [1]. There are a total of 29 amino acid differ-
ences between these two viruses spanning the length of
the viral genome, as well as deletions of two amino acids
in the nucleocapsid protein of MERS-CoV Eng 1 com-
pared to MERS-CoV SA 1 [14].
Results and discussion
Using a human airway cell culture model, we sought to
understand which specific signaling events would be deter-
minant components of the host response to MERS-CoV
infection. We took a genomics-based approach and
assessed the whole transcriptome by microarray analysis
to 1) topologically characterize the kinetic and magnitudi-
nal changes in the host response elicited by MERS-CoV
Eng 1 and MERS-CoV SA 1 and 2) identify contrasting
genes between the two viruses related to innate and pro-
inflammatory signal stimulation. Utilizing cytokine treat-
ment transcriptomic data sets derived from the same model
system, we pursued cytokine signaling events in MERS-
CoV-infected Calu-3 cells driving statistically significant
contrasting gene expression observed between MERS-CoV
Eng 1 and MERS-CoV SA 1. On the basis of the virus-
contrasting genes, we predicted STAT3 as a regulator of
MERS-CoV-induced host responses, with strain-specific
differences in STAT3-mediated gene expression.
Topological characterization of the host response shows
spatio-temporal transcriptomic differences between
MERS-CoV strains
Human Calu-3 2B4 cells were infected with one of
two different MERS-CoV strains, MERS-CoV SA 1 or
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were harvested throughout the infection course for micro-
array analysis. We first characterized topological differ-
ences of the whole transcriptome on Euclidean metric
space for the collection of 93 samples (mock, MERS-CoV
SA 1, MERS-CoV Eng 1 and icSARS-CoV) using recent
methods from computational topology, including persist-
ence homology [15,16]. Many data reduction methods rely
on embedding high-dimensional data into two dimen-
sions. Multi-dimensional scaling (MDS), for example,
calculates coordinates for a 2-dimensional embedding
of the experimental data by minimizing the deviation
between embedded and original data (Kruskal stress).
Persistence homology, on the other hand, performs
computation of topological invariants in the dimension
of the original dataset and is, unlike MDS, more stable
under perturbation. To assess global kinetic dissimilarities
across different CoV infections, we calculated topological
differences between MERS-CoV SA 1, MERS-CoV Eng 1
and icSARS-CoV, each grouped throughout all time points
and with data set-matched mock samples. The kinetics of
the host response refers to the spread of infected samples
relative to mock samples over time. There were large
topological differences between MERS-CoV Eng 1 and
icSARS-CoV (score: 2.42), and between MERS-CoV SA 1
and icSARS-CoV (score: 2.18), and moderate differences
between MERS-CoV Eng 1 and MERS-CoV SA 1 (score:
0.29) (Methods and Table 1).
To further assess the magnitude impact of MERS-CoV
infection in Calu-3 2B4 cells, we integrated viral genomic
RNA levels into a topological assessment of host response
differences. MERS-CoV genomic RNA was measured by
qRT-PCR using primer (KL200F) located in the leader
region (nt 9-28) and primer (KL201) located in the ORF1
region of the CoV genome (Figure 1A and Additional
file 1: Table S5). Additionally, we measured viral titers
by plaque assay and found MERS-CoV SA 1 had more
robust infectious viral particle production than MERS-
CoV Eng 1, with significantly different viral titers at 18
and 24 hpi, despite similar viral genomic RNA levels at
these late time points (Additional file 2: Table S4). In
measuring viral genomic RNA and infectious viral par-
ticle production, we assessed two different stages in theTable 1 Topological assessment of normalized log2 expressio
either IFN or pro-inflammatory cytokine treatment for MERS-
Topological difference of normalized log2 expression MER
1 t
Whole transcriptome
Restricted to IFN-α and IFN-γ stimulated genes
Restricted to TNF and IL-1α stimulated genes
For comparison of topological differences in the host response, we calculated persi
The differences between bar codes were calculated using a maximal bipartite graphviral life cycle and the data support differences in the
kinetics of replication for the two MERS-CoV strains.
Since our analysis focuses on the host response to infec-
tion and its origin in pathogen recognition and activa-
tion of innate immune responses, we computationally
integrated viral genomic RNA with host mRNA to
better assess the differences in host response kinetics.
Towards this end, we used a filtered clustering method
[17] that reduced the space of 93 samples to a clustering
graph of 18 nodes. First, the viral genomic RNA levels
were used as a filter to bin the samples into overlapping
subsets with similar viral load (i.e., viral gRNA). Second,
within each subset, samples that showed a high degree
of interconnection were retained. Thus, there was high
similarity in gene expression levels within each subset.
For a graphical representation, each set of retained
samples formed a node and nodes were considered as
adjacent whenever they had at least one sample in com-
mon (Methods and Figure 1B). Mock-infected samples
were all in one isolated cluster. With increasing viral
load, the temporal delay between MERS-CoV Eng 1 and
MERS-CoV SA 1 started as early as 3 hours post infec-
tion (hpi), with 3 and 7 hpi MERS-CoV Eng 1 samples
clustering with 7 and 12 hpi MERS-CoV SA 1 samples.
Genomic RNA levels at 18 and 24 hpi between the two
viruses were not statistically different as determined by
the non-parametric Mann-Whitney test. Despite similar
viral gRNA at 18 and 24 hpi (Figure 1A), the filtered
clustering approach demonstrated MERS-CoV Eng 1 and
MERS-CoV SA 1 were distinct at the late time points,
with 18 and 24 hpi MERS-CoV Eng 1 samples separated
from 24 hpi MERS-CoV SA 1 samples (Figure 1B).
Taken together, these whole transcriptome topological
analyses showed robust differences in both kinetics and
magnitude of the host response between MERS-CoV SA
1 and MERS-CoV Eng 1, despite similar viral replication.
Another example where viral replication may not be the
best readout of host response differences is icSARS-CoV.
The deletion of the entire ORF6 gene of icSARS-CoV
(icSARS-CoV ΔORF6) does not impact viral replication
compared to wild-type icSARS-CoV, yet substantial differ-
ences in the host response between the two viruses are
detected in Calu-3 2B4 cells [18].n for the whole transcriptome and genes restricted to
CoV Eng 1, MERS-CoV SA 1 and icSARS-CoV conditions
S-CoV SA
o Eng 1
MERS-CoV SA 1
to icSARS-CoV
MERS-CoV Eng 1
to icSARS-CoV
0.29 2.19 2.43
0.74
0.35
stence homology bar codes for data set-matched mock and infected samples.
matching algorithm. For icSARS-CoV we also included 30 and 36 hpi samples.
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Figure 1 Human airway epithelial cell culture model of MERS infection and the kinetics of the host response. A. Calu-3 2B4 cells were
infected with either MERS-CoV SA 1 or MERS-CoV Eng 1 (MOI 5). Cell lysates were harvested at 3, 7, 12, 18 and 24 hpi and viral genomic RNA
measured by qRT-PCR using forward primer (KL200F) and reverse primer (KL201) spanning the CoV genome (Additional file 1: Table S5). The error
bars represent the standard deviation among triplicate samples. B. Clustering graph for samples according to their Euclidean distances in gene
expression obtained by an integration of viral genomic RNA levels. Samples with similar viral genomic RNA levels were grouped together. Using
statistical criteria on the single linkage heights between all samples, we extracted the highly interconnected part (with smaller linkage heights).
These samples were compared to highly interconnected samples of a second group of samples with overlapping viral genomic RNA levels of the
first group and so forth. Whenever two highly interconnected parts had at least one sample in common we defined the two groups as adjacent.
In the clustering graph, adjacent sample groups are linked by an edge, the node color represents the average viral genomic RNA levels of each
sample group. Edge length or distance between nodes in the graph does not recapitulate spatial closeness of samples.
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differences in epithelial adherens junction signaling and
pro-inflammatory cytokine signaling late in infection
Differential gene expression between MERS-CoV Eng 1
and MERS-CoV SA 1 was directly examined by comparing
fold changes with respect to time- and experiment-
matched mocks (absolute log2 FC > 1, FDR-correctedp-value < 0.05). We found the most robust transcrip-
tional changes to MERS-CoV SA 1 and MERS-CoV
Eng 1 infections occurred at the late times points (18 and
24 hpi). Compared to MERS-CoV SA 1 there was an
accelerated host response to MERS-CoV Eng 1, with
differential gene expression observed as early as 7 hpi.
As shown in Figure 2, MDS representation of MERS-CoV
Figure 2 Multidimensional scaling representation for Calu-3 MERS-CoV and SARS-CoV infections. Calu-3 2B4 cells were infected with either
MERS-CoV SA 1 or MERS-CoV Eng 1 (MOI 5) and cell lysates were harvested at 0, 3, 7, 12, 18 and 24 hpi. Calu-3 2B4 cells were infected with icSARS-CoV
(MOI 5) and cell lysates were harvested at 0, 3, 7, 12, 24, 30 and 36 hpi. Samples are clustered based on 6432 DE genes changing in at least one virus
condition and at one time-point The quality of the representation is provided by the Kruskal Stress criteria, with the relatively low percentage of Kruskal
stress (8.22%) suggesting a faithful 2D representation of the statistically observed transcriptional differences between MERS-CoV SA 1, MERS-CoV Eng 1
and icSARS-CoV.
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6432 DE genes changing in at least one virus condition
and at one time-point confirmed the early onset of host
responses to MERS-CoV Eng 1 infection and the
sustained separation between MERS-CoV Eng 1 and
MERS-CoV SA 1 beginning at 18 hpi. The MDS repre-
sentation also showed MERS-CoV Eng 1 samples in an
intermediate position between MERS-CoV SA 1 and
icSARS-CoV, with the host response to icSARS-CoV
being largely delayed until 30 and 36 hpi. There is
increasing evidence that interferon (IFN) antagonism
and avoidance of interferon-stimulated gene (ISG)
effector functions are major contributors to the delayedhost response in icSARS-CoV infection [18,19]. In this
context, the intermediate positioning of MERS-CoV
Eng 1 between MERS-CoV SA 1 and icSARS-CoV led
us to investigate MERS-CoV strain-specific differences
in innate immune signaling early in infection and the
subsequent impact on the later host response.
The greatest number of gene expression differences
between MERS-CoV SA 1 and MERS-CoV Eng 1 were
induced at the late time points, with 2160 genes and
2611 genes differentially expressed (DE) at 18 and 24
hpi, respectively (Figure 3A). There was a total of 4861
DE genes between MERS-CoV SA 1 and MERS-CoV
Eng 1 in at least one time point (herein known as
AB
MERS-CoV Eng 1 MER-CoV SA 1
3
log2 FC vs mock
7 12 3 7 12
hours post infection
-2  1  0  1  2
Figure 3 Differentially expressed genes following MERS-CoV SA 1 and MERS-CoV Eng 1 infections. A. Statistically significant DE genes
between MERS-CoV SA 1 and MERS-CoV Eng 1 were identified at 3, 7, 12, 18 and 24 hpi (absolute log2 FC > 1, FDR-corrected p-value < 0.05). The
bargraph shows the number of up-regulated and down-regulated DE genes between MERS-CoV SA 1 and MERS-CoV Eng 1 at each time point.
B. Heatmap of differentially expressed genes following MERS-CoV SA 1 and MERS-CoV Eng 1 infection shows more than four hundred genes
uniquely expressed in MERS-CoV Eng 1 infected cells at early time points (between 3 and 12 hpi), with differential expression criteria of absolute
log2 FC > 1 against time- and dataset-matched mocks, FDR-corrected p-value < 0.05).
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there was an earlier host response to MERS-CoV Eng 1
at 7 and 12 hpi. The accelerated Calu-3 response to
MERS-CoV Eng 1 may be the result of the difference in
kinetics of viral gRNA replication, with MERS-CoV Eng
1 more efficiently replicating at 3 and 7 hpi compared to
MERS-CoV SA 1 (Figure 1A). Alternatively, the delay in
the host response to MERS-CoV SA 1 may be due to the
virus more efficiently evading innate immune responses
that leads to enhanced viral replication compared to
MERS-CoV Eng 1 (Additional file 2: Table S4). Between
the two viruses there are amino acid differences in ORF4a
and PLpro, viral proteins known to modulate the innate
immune response during MERS infection [5-7]. We
further examined host gene expression at the early
time-points (3, 7 and 12 hpi) and found significant en-
richment of genes associated with the STAT3 pathway.
STAT3 pathway genes CDC25A, MYC, SOCS3 and
SOCS4 were more strongly induced by MERS-CoV Eng
1 compared to MERS-CoV SA 1, particularly at 7 hpi
(Figure 3B). Increased SOCS gene expression and de-
creased expression of PIM1 gene in response to
MERS-CoV Eng1 indicated decreased STAT3 activity
and possibly differential induction of apoptosis-related
pathways. In a direct virus comparison, differential ex-
pression of pro-apoptotic BID, BAX, and BIM genes
was observed at the early time-points and by 24 hpi
there was extensive cytopathic effects caused by both
viral infections that was likely the result of caspase-
dependent apoptosis, as previously shown for MERS
infection [20]. Of the 4861 contrasting genes, 2653
genes were also DE against time- and data set-matched
mocks. Hierarchical clustering of the 4861 DE genes
resulted in distinct gene clusters, with striking expres-
sion pattern contrasts between MERS-CoV SA 1 and
MERS-CoV Eng 1 at 18 and 24 hpi. As shown in
Table 2, functional analysis of the five most prominent
clusters with contrasting gene expression revealed
enrichment of integrin linked kinase (ILK) signaling and
epithelial adherens junction signaling pathways, glutathi-
one metabolism, and interferon and pro-inflammatory
signaling pathways. Genes related to glutathione metabol-
ism included GSTM1 and GSTM3, which were strongly
downregulated in response to both viruses. ISGs, IFIT1
and IFIT3, were highly induced in response to both
MERS-CoV Eng 1 and MERS-CoV SA 1, with pro-
nounced early up-regulation specifically in response to
MERS-CoV Eng 1. Genes associated with ILK signaling
and epithelial adherens junction signaling pathways were
strongly downregulated in response to MERS-CoV SA 1,
whereas MERS-CoV Eng 1 predominantly up-regulated
expression of these genes at the late time points
(Additional file 3: Figure S1). Within the highly enriched
pathways, cellular genes including PVRL1, RHOF andCREBBP with highest expression contrasts between the
two infections were chosen for confirmation by qRT-PCR
(Additional file 4: Figure S2). Pro-inflammatory CSF3 gene
was found more highly induced by MERS-CoV SA 1
(log ratios in MERS-CoV SA1 and MERS-CoV Eng1
respectively: 2.2 and 0.5), whereas CCL5 gene was
more highly induced by MERS-CoV Eng 1 (log ratios
in MERS-CoV SA1 and MERS-CoV Eng1 respectively:
0.71 and 2.2). Examination of the aforementioned
contrasting genes showed that only a small number of
those were already differentially expressed at the early
time-points. For example, expression of RHOF gene in
response to MERS-CoV Eng 1 was increased 4-fold
relative to mock at 12 hpi, whereas MERS-CoV SA 1
did not induce RHOF gene expression at this time-
point. We therefore focused on differences in the host
response mainly at the later time-points that had the
highest number of contrasting genes.
MERS-CoV Eng 1 and MERS-CoV SA 1 elicit differences in
the timing of cytokine-mediated innate immune and
pro-inflammatory responses in Calu-3 cells
While there was no difference in IFN- β gene expression
detected between the two MERS-CoV strains, there was
differential IFN-α2 and IFN- γ gene expression. Specific-
ally, expression of IFN-γ was downregulated early after
infection in MERS-CoV Eng 1-infected Calu-3 cells and
up-regulated in MERS-CoV SA 1-infected Calu-3 cells.
To some extent, this was also observed for IFN-α2
gene expression, which showed higher up-regulation in
response to MERS-CoV SA 1 at 24 hpi, as confirmed
by qRT-PCR (Additional file 4: Figure S2). In addition,
IFN-λ1 and IFN-λ2 were DE relative to mock with high
up-regulation at 18 and 24 hpi for both viruses.
There were no virus-specific differences in expression of
pro-inflammatory cytokines, IL-1α or TNFα-IP3, which
were highly up-regulated in response to both MERS-CoV
Eng 1 and MERS-CoV SA 1. The cell migration-
promoting factor, TNFα-IP2 [21], was highly up-regulated
for MERS-CoV Eng 1 alone (Additional file 4: Figure S2).
Cytokines appear to be important for MERS infection. To
explore potential mechanisms regulating cytokine activ-
ity in response to MERS-CoV, we designed a microarray
experiment to analyze Calu-3 responses to various cyto-
kine treatments and develop signatures that were then
examined in the context of MERS-CoV-infected Calu-3
cells. Calu-3 cells were treated with either human re-
combinant interferon IFN-α, IFN-γ, TNF or IL-1α, and
cell lysates collected at different time points post-
treatment for microarray. We found 399 DE genes
responsive to recombinant IFN-α and 261 DE genes
responsive to recombinant IFN-γ, and as expected, the
majority of these genes were up-regulated following
stimulation [22]. In response to pro-inflammatory cytokine
Table 2 Canonical Pathways enriched in human airway cells infected with MERS-CoV
MERS virus Canonical pathwaya -log p-val molb molc
MERS-CoV Eng 1 vs MERS-CoV SA 1 Role of Macrophages, Fibroblasts and
Endothelial Cells in RA
5.80 94/342
(4861 DEG) Tumoricidal Function of Hepatic Natural Killer Cells 3.77 13/27
VDR/RXR Activation 3.66 29/88
Wnt/β-catenin Signaling 3.63 53/175
G-Protein Coupled Receptor Signaling 3.60 74/276
Cluster 2 Wnt/β-catenin Signaling 5.40 23/175
(1108 DEG) NGF Signaling 5.11 17/122
Epithelial Adherens Junction Signaling 4.89 20/154
PPARα/RXRα Activation 4.68 22/200
ILK Signaling 4.27 22/205
Cluster 4 Glutathione-mediated Detoxification 5.51 5/45
(194 DEG) Antigen Presentation Pathway 4.89 5/42
Ascorbate Recycling (Cytosolic) 3.69 2/13
Glutathione Redox Reactions I 3.46 2/24
Aryl Hydrocarbon Receptor Signaling 2.95 6/171
Cluster 10 Notch Signaling 3.17 6/43
(648 DEG) 1D-myo-inositol Hexakisphosphate Biosynthesis
II (Mammalian)
1.79 3/28
D-myo-inositol (1,3,4)-trisphosphate Biosynthesis 1.79 3/25
Ephrin B Signaling 1.71 6/82
Tumoricidal Function of Hepatic Natural Killer Cells 1.52 3/27
Cluster 11 Interferon Signaling 2.40 2/36
(61 DEG) Phenylethylamine Degradation I 1.96 1/11
IL-17A Signaling in Airway Cells 1.87 2/76
BMP signaling pathway 1.74 2/86
TGF-β Signaling 1.66 2/94
Cluster 12 (576 DEG) Differential Regulation of Cytokine Production in
Macrophages and T Helper Cells by IL-17A and IL-17 F
3.24 4/18
Role of Cytokines in Mediating Communication
between Immune Cells
2.87 6/54
Differential Regulation of Cytokine Production in
Intestinal Epithelial Cells by IL-17A and IL-17 F
2.82 4/23
G-Protein Coupled Receptor Signaling 2.71 14/276
Agranulocyte Adhesion and Diapedesis 2.55 11/192
Ingenuity Pathway Analysis was used to determine significant Canonical Pathways for the entire heatmap of contrasting genes (MERS-CoV Eng 1 vs MERS-CoV SA
1) and for individual Clusters 2, 4, 10, 11, and 12 that had the most contrasting patterns of gene expression at 18 and 24 hpi.
aRA: Rheumatoid Arthritis.
bNumber of molecules differentially expressed in the canonical pathway.
cTotal number of molecules in the annotated canonical pathway.
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http://www.biomedcentral.com/1471-2164/15/1161treatment, we found 76 DE genes responsive to recom-
binant TNF and 383 DE genes responsive to recombin-
ant IL-1α, which were also differentially expressed in
response to MERS-CoV SA 1 or MERS-CoV Eng 1. Many
of these genes showed cytokine-specific expression for
IFN-α (260 DE genes), IFN-γ (107 DE genes), and IL-1α
(209 DE genes (Figure 4A). TNF induced the least number
of DE genes compared to the other cytokines (8 DEgenes). Within the cytokine-stimulated genes we identified
a set of 149 genes showing strong contrasts at late time
points (18 and 24 hpi) between MERS-CoV SA 1 and
MERS-CoV Eng 1 (Figure 4B).
Topological analysis of gene expression restricted to IFN
and pro-inflammatory cytokine genes sets revealed IFN
induction (score: 0.74) as a major contributor to kinetic
differences between MERS-CoV SA 1 and MERS-CoV
AB
MERS-CoV
 Eng 1
MER-CoV
SA 1
24 hpi18 hpi
log2 FC vs mock
-2 0 2
IL1α TNF IFNγ IFNα
IFNα
IL1αTNF
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Figure 4 Differential cytokine stimulated gene expression in human airway epithelial cells infected with distinct MERS-CoVs. A. Venn
diagram shows the number of genes which were DE after infection in any one virus or time point and their overlap within four sets of different
cytokine stimulation. Whereas IFN-α, IFN-γ and IL-1α show a large number of specific genes, TNF stimulated DE genes share many genes with
other cytokines B. Heatmap of 149 DE genes following either MERS-CoV SA 1 or MERS-CoV Eng 1 infection (MOI 5) that show strong contrasts at
18 and 24 hpi. The black bars on the left of the heatmap indicate whether genes were also DE after cytokine treatments (IFN-α, IFN-γ, IL-1α, TNF-α) in
the same cell line system as the infection.
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http://www.biomedcentral.com/1471-2164/15/1161Eng 1 infection (Table 1). The relative numbers of cyto-
kine genes, which were also DE after MERS-CoV SA 1
or MERS-CoV Eng 1 infection (22% for IFN-α, 31%
for IFN-γ, 31% for IL-1α and 45% for TNF), indicatedthe contribution of these specific gene sets to global gene
expression changes in MERS infection. Functional analysis
of the cytokine DE genes showed antigen presentation
pathway was significantly enriched in MERS-CoV-induced
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with adaptive immune responses such as OX40 signaling
and cytotoxic T lymphocyte-mediated apoptosis pathways.
IFN-α response genes were significantly enriched for
cellular pathways involved in the antiviral response,
such as interferon regulatory factor (IRF) activation by
pathogen recognition receptors (PRRs). Pro-inflammatory
mediators, IL-1α and TNF, which stimulate genes related
to IL-17 signaling, were identified following MERS infec-
tion. For example, pro-inflammatory cytokine genes,
CXCL1, CCL2, and CCL20, regulated by IL-17A [23] and
play a prominent role in airway inflammation and disease,
and NF-κB genes, NFKBIA, NFKB2 and NFKBIE, were all
found to be DE in response to TNF and MERS-CoV
infection.
Predicted role for STAT3 in mediating gene expression
changes between MERS-CoV Eng 1 and MERS-CoV SA 1 in
Calu-3 infected cells
To further investigate potential regulators mediating the
gene expression contrasts between MERS-CoV Eng 1
and MERS-CoV SA 1 at the late time points, we per-
formed an Upstream Regulator Analysis in Ingenuity
Pathway Analysis (IPA) that identifies upstream tran-
scriptional regulators based on the observed gene ex-
pression changes in the experimental data set and
compiled knowledge of reported relationships between
regulators and their known target genes within the
Ingenuity Pathway Knowledge Base. The NUPR1 gene
encoding a transcription factor known as stress-activated
nuclear protein 1 had a predicted inhibition (z-score
of -2.373) for MERS-CoV SA 1 and predicted activation
(z-score of 3.226) for MERS-CoV Eng 1 at 18 hpi
(Table 3). This LPS-induced transcription factor is an
important regulator of apoptosis, cell proliferation and
autophagy [24-26]. Differentially expressed genes be-
tween MERS-CoV SA 1 and MERS-CoV Eng 1 that are
binding partners and downstream targets, such as
EP300 and TESK1, shown in Additional file 3: Figure
S1, were downregulated in MERS-CoV SA 1 virus-
infected cells at 18 and 24 hpi and up-regulated in
MERS-CoV Eng 1 virus-infected cells at these late time
points, corroborating the predicted NUPR1 regulator
status in response to these two MERS-CoV strains.
We also identified STAT3 as a predicted upstream
regulator at 24 hpi in response to MERS-CoV Eng 1
(z-score = 2.559), with up-regulation of downstream tar-
get genes including BCL6, SOCS3, BCL3, IRF7 and PML
(Figure 5, Table 3). Through a separate binding motif
prediction analysis using JASPAR and PSCAN, we con-
firmed the STAT3 prediction based on enrichment of
STAT3 binding sequences in DE genes at the late time
points (Table 3). Conversely, MERS-CoV SA 1 infection
resulted in downregulation of these same target genes,suggesting a predicted inhibition or delay in STAT3
regulator activity, though STAT3 did not reach a statis-
tically significant z-score (z-score = 0.364). Among the
STAT3 target genes BCL3 had the highest contrasting
expression between the viruses. The BCL3 gene was
highly up-regulated in response to MERS-CoV Eng 1
(FC = 1.5) and downregulated in response to MERS-
CoV SA 1 (FC = -1.66) at 18 hpi. qRT-PCR analysis of
BCL3 mRNA expression, and several additional STAT3
target genes, including BCL6, PML, and IRF7, were in
agreement with the microarray findings (Additional file 4:
Figure S2). Among these genes, IRF7 plays an important
role in the cellular antiviral response and Faure and
colleagues reported high levels of IRF7 gene expression
in BAL cells from a patient that recovered from MERS
infection [12].
STAT3 acts as a critical regulator of cellular repair
processes upon acute lung injury and BCL3 has been
shown to reduce lung inflammation in mice by regulat-
ing granulocytes [27]. In addition to BCL3, several other
contrasting STAT3 target genes, including BCL6, IL11,
and PML, have been reported to impact pro-inflammatory
responses [28-30], epithelial integrity and the severity of
lung injury after infection [27,31]. We postulate the differ-
ence in pro-inflammatory cytokine gene expression may
be the result of differential STAT3 activity. For example,
SARS-CoV directly impacts STAT3 activity by dephos-
phorylating STAT3 at Tyr-705 after 18 hpi in infected
Vero E6 cells [32]. Here, the MERS-CoV strain-specific
differences may be a causative factor in leading to differ-
ential STAT3 activation and the down-stream effects of
pro-inflammatory responses.
Conclusion
MERS-CoV is a novel pathogenic coronavirus and the
innate and inflammatory response during MERS infec-
tion is poorly understood. Using an established human
airway culture model we found differences in host gene
expression between MERS-CoV SA 1 and MERS-CoV
Eng 1 that support the hypothesis of strain-specific differ-
ences related to functional differences in the sensitivity to
innate immune responses [4]. Through our genomics-
based approach, we found (i) topological differences in the
kinetics and magnitude of the host response to MERS-CoV
SA 1 and MERS-CoV Eng 1, with (i) a precursory host
response in MERS-CoV Eng 1-infected cells, (ii) differen-
tial expression of innate immune and pro-inflammatory
responsive genes between MERS-CoV Eng 1 and MERS-
CoV SA 1 that may be associated with downstream effects
of IFN, TNF and IL-1α signaling, and (iii) a predicted acti-
vation for STAT3 mediating gene expression relevant for
epithelial cell remodeling in MERS-CoV Eng 1 infection.
At present, nonhuman primates serve as the best avail-
able model of MERS-CoV pathogenesis, with animals
Table 3 Upstream regulators with predicted Activation and Inhibition states distinguishing MERS-CoV Eng 1 and
MERS-CoV SA 1 infections
Upstream regulator p-value of overlap MERS-CoV SA 1_18h MERS-CoV Eng 1_18h MERS-CoV SA 1_24h MERS-CoV Eng 1_24h
STAT3 3.82E-14 -0.253 1.958 0.364 2.559
CTNNB1 1.20E-13 -1.187 1.465 -1.998 1.515
ESR1 1.82E-12 0.519 -0.728 -0.21 -1.083
NFKBIA 2.30E-10 0.604 1.108 0.635 1.477
NUPR1 2.40E-10 -2.373 3.226 -0.347 2.705
SP1 4.13E-10 -2.222 2.021 -1.62 0.831
NR3C1 5.66E-10 -2.65 -0.895 -1.582 -1.658
CREB1 1.86E-09 -2.138 2.52 -1.085 1.582
CEBPA 3.63E-09 0.39 -1.513 0.075 -1.162
JUND 3.71E-09 1.248 0.282 0.443 -0.201
HIF1A 1.32E-08 -0.442 0.622 -0.801 1.993
TP53 1.89E-08 -1.46 0.719 -1.608 1.228
AHR 2.57E-08 1.482 1.642 0.227 0.984
FOS 2.64E-08 0.188 0.188 0.188 1.076
FOXO3 2.76E-08 0.086 0.685 -0.198 -0.457
Histone h3 2.81E-08
CEBPB 6.11E-08 0.795 -0.929 -0.242 0.845
TP63 6.62E-08 -0.084 1.834 -0.557 0.605
NFKB1 1.35E-07 -0.025 0.564 0.93 0.867
NFATC3 1.52E-07 -1.082 0.8 -0.687 -0.286
PDX1 1.95E-07 1.223 1.206 1.077 1.673
SMARCA4 2.10E-07 -1.283 0.435 -0.377 1.115
EGR1 2.16E-07 0.38 1.407 -0.626 0.464
Ap1 5.52E-07
CREM 6.36E-07 -0.951 1.412 -0.254 2.437
FOXL2 6.57E-07 1.267 2.428 0.682 3.559
Ingenuity Pathway Analysis was used to determine the top 20 Upstream Regulators. z-scores for predicted upstream regulators (|z| >2) at each time point are
shown. z >2 predicts activation of the upstream regulator. z < -2 predicts inhibition of the upstream regulator. The Activation z-score was used to rank the Upstream
Regulator based on the “Inhibited” status (darker cells indicated more significant “Inhibited” status of Upstream Regulator).
Upstream Regulators in bold indicates enrichment of DNA-binding motifs (human) via TRANSFAC promoter analysis intersected DE genesets for MERS-CoV Eng 1
and MERS-CoV SA 1 at either 18 or 24 hpi (q-value of 10-7).
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topathologic changes in the lung [33,34]. While there
is no current small-animal model of MERS infection,
immunocompromised mice transduced with an adeno-
viral vector expressing human DPP4 show increased
susceptibility to MERS-CoV infection [35]. In a separate
study, a variant of Pipistrellus bat coronavirus (BtCoV)
strain HKU5 expressing the SARS-CoV spike (S) glycopro-
tein ectodomain (BtCoV HKU5-SE) resulted in enhanced
morbidity and acute changes in lung histopathology in
aged BALB/c mice following mouse adaptation [36].
The present cytokine systems approach provides valuable
insight into differences of cellular antiviral responses to
distinct MERS-CoV strains. In line with these observa-
tions, reversal of infection gene signatures that can attenu-
ate viral replication or enhance innate immune responsesto the most highly pathogenic MERS-CoV strain could
be investigated in this model system. We are beginning
to better understand that different MERS-CoV strains
can result in variable host responses, as observed with the
recent clinical study by Faure and colleagues [12]. The
patients infected with MERS-CoV SA 1 and MERS-CoV
Eng 1 had both a fatal outcome, with the MERS-CoV SA
1-infected patient succumbing to infection within 11 days
after admission, 18 days to death following initial symp-
toms [1]. The MERS-CoV Eng 1 patient on the other hand
had an initially transient illness and then rapidly declined
to a severe acute respiratory distress syndrome remaining
in this state for 9 months before death [2]. Having an effi-
cient innate immune response likely dictates a patient’s
disease progression and would thus be a primary goal for
in silico drug predictions, which could then be tested
MERS-CoV Eng 1
MER-CoV SA 1
Figure 5 STAT3 is a predicted regulator mediating the gene constrasts between MERS-CoV Eng 1 and MERS-CoV SA 1. Upstream
Regulator Analysis in IPA was used to predict regulators and infer their activation state based on the literature and gene expression of target
genes in the data set. STAT3 is the master regulator of a small causal network that postulates differential STAT3 activity in MERS-Co-V SA 1 and
MERS-CoV Eng 1 infections. STAT3 activity affects a number of other regulators that explains the downstream gene expression changes in the
data set. The color of the lines (edges) signifies the expected direction of effect between two nodes. Blue represents predicted inhibition and
orange represents predicted activation. Yellow signifies inconsistency between the gene expression in the data set and the annotated relationship.
The color of the node signifies the z-score calculated from the data set. Blue: z-score < -2 and orange: z-score > 2. The downstream genes show gene
expression in infected cells relative to mock-infected cells. Green: down-regulated expression and red: upregulated expression).
Selinger et al. BMC Genomics 2014, 15:1161 Page 12 of 16
http://www.biomedcentral.com/1471-2164/15/1161in vitro with a particular focus on cytokine stimulated
genes [37]. Toward this end, extending the collection
of transcriptomic profiles to include more MERS-CoV
strains will be important for a deeper view of the host
response during MERS infection and toward a greater
understanding of MERS-CoV pathogenicity.
Methods
Cells and viruses
Calu-3 2B4 cells were cultured in minimal essential media
(MEM; Gibco) supplemented with 20% fetal bovine serum
(HyClone) and 1% antibiotic antimycotic (Gibco). Human
coronavirus MERS-CoV SA 1 (GenBank: JX869059.2)
was received from Bart L. Haagmans (Erasmus Medical
Center, Rotterdam, Netherlands). MERS-CoV SA 1 was
isolated from the sputum of a 60-year-old man in Saudi
Arabia who died after developing acute respiratory distresssyndrome (ARDS) in June 2012 [1]. Human coronavirus
MERS-CoV Eng 1 (GenBank: KC667074.1) was received
from the United Kingdom Health Protection Agency
(HPA) Imported Fever Service. MERS-CoV SA 1 and
MERS-CoV Eng 1 were propagated in VeroE6 cells and
supernatants clarified. For questions of written informed
consent for participation in the study, we refer to [1] and
[2], where isolation of viruses from clinical samples is
described. Virus stocks were tittered on VeroE6 cells using
standard methods, as previously described [14]. SARS-
CoV experiments were derived from the infectious clone
of SARS-CoV (icSARS-CoV) as described in [18,38].
Calu-3 2B4 infections
All work was performed in a biosafety level 3 (BSL3)
facility at the University of North Carolina-Chapel Hill.
Cells were washed with phosphate-buffered saline (PBS)
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(MOI) of 5 plaque-forming unit (PFU) per cell or mock
diluted in PBS for 40 min at 37°C. Following inoculation,
cells were washed 3 times, and fresh medium was added.
Triplicate infected Calu-3 2B4 cultures and triplicate
time-matched mock-infected controls were harvested at
0, 3, 7, 12, 18 and 24 hpi.Cytokine treatment of Calu-3 cells
Calu-3 cells were treated with either IFN-α (10 ng/ml)
(Sigma I4276), IFN-γ (500 U/ml) (Sigma I32265), IL-1α
(0.001 ng/ml) (Peprotech, #200-01A) or TNF (0.05 ng/ml)
(Peprotech, #300-01A) in triplicate for each cytokine.
Treated cell lysates (n = 3) and time-matched mock-
treated cell lysates (n = 3) were harvested at 0, 3, 6, and
18 hr following IFN-α treatment, at 0, 3, 6, and 21 hr
following IFN-γ treatment, at 3, 6, and 24 hr following
IL-1α treatment, and at 6 hr following TNF treatment.
Total RNA was extracted from each sample and gene
expression analyzed by microarray. Probe labeling and
microarray slide hybridization for pooled replicates for
each treatment per time-point was performed using
Human Genome CGH Microarray (G4447A; Agilent
Technologies).RNA isolation and microarray processing
RNA isolation from Calu-3 2B4 cells infected with
MERS-CoV SA 1 and subsequent hybridization to Agilent
4 × 44K human HG arrays was previously reported in
[11]. RNA isolation from Calu-3 2B4 cells infected with
MERS-CoV Eng 1 was performed following the same
protocol used for MERS-CoV SA 1-infected Calu-3
samples and used for subsequent hybridization to Agilent
8 × 60K human arrays. Calu-3 2B4 microarray experi-
ments with an infectious clone recombinant SARS-CoV
(icSARS-CoV) (AY278741) was reported in [18]. Using
Agilent QC criteria we removed one 12 hpi replicate
infected with MERS-CoV SA 1 and one 7 hpi replicate
infected with MERS-CoV Eng 1. Due to the absence of
mock samples at 24 hpi in the MERS-CoV Eng 1, we
used the mock samples harvested at 18 hpi for the com-
parison at 24 hpi. In order to merge MERS-CoV Eng 1
and MERS-CoV SA1 data sets, we considered only
probes that were mapped to gene names (Refseq IDs) in
both arrays. To remove batch effects from the merged
data sets we applied the R function ComBat [39]. The
resulting data set was then quantile normalized. For
each sample, a log2 fold change value was calculated
as a difference between log2 normalized data for each
sample and the average of log2 normalized data for
time- and data set-matched mock-infected samples. The
same procedure, but handled as separate data sets, was
applied to the cytokine treatment microarray data sets.Statistical analysis
Statistical analyses for viral genomic RNA and viral titer
changes in Calu-3 2B4 cells infected with either MERS-
CoV SA1 or MERS-CoV were performed by using two-
sided non-parametric Mann-Whitney U test (Additional
file 2: Table S4).
Topology analysis
For normalized intensity data, the Euclidean distance
matrix between samples was clustered with respect to
sample-matched viral genomic RNA measurements
using an algorithm described in [17]. We used a freely
available MATLAB implementation of this algorithm
(http://appliedtopology.org/) with the parameter setting
filterSamples = 5, pverlapPct = 65, mFudge = 5. The
topology induced by a distance matrix can be described
by a filter function, which assigns to every sample a
value (phenotypic outcome, viral load, etc.). First, the
topological space is decomposed into overlapping sub-
sets using level sets of the filter function. The set of
samples falling into a particular subset are clustered, and
the cluster tree is partitioned into two parts using statis-
tical criteria of the single linkage length. Only the part of
the cluster tree with small linkage lengths (dense part) is
retained. If resulting filtered clusters of different subsets
have at least one sample in common, then they are de-
fined as adjacent in a global discrete cluster graph.
Topological differences between MERS-CoV SA 1 and
MERS-CoV Eng 1 gene expression during the course of
infection was furthermore assessed using homology per-
sistence barcodes (only 0- and 1-homology were taken
into account) as described in [15]. For calculations, we
used the freely available R package phom [40] and their
maximum weighted bipartite graph matching [41] as a
measure of difference (see R script implementation in
Additional file 5). Additionally, multi-dimensional scal-
ing (MDS) was performed on the Euclidean distance
matrix between samples after differential gene expres-
sion statistical analysis [42].
Differential gene expression analysis
Differential expression was determined by comparing
MERS-CoV SA 1- and MERS-CoV Eng 1-infected rep-
licates to time- and data set-matched mock-infected
controls, based on a linear model fit for each probe
using the R package Limma [43]. The same method was
applied to determine differential expression between
strains using time-matched MERS-CoV SA 1- and MERS-
CoV Eng 1-infected samples. Criteria for differential
expression were an absolute log2 fold change of 1 and a
q value of <0.05 calculated using a moderated t test with
Benjamini-Hochberg correction. The cytokine Calu-3
treatment data sets were analyzed separately using the
same methods and cut-offs as the virus-infected Calu-3
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be statistically significant in at least on time point and
for at least one treatment.Quantitative reverse transcription PCR (qRT-PCR)
RNAs were reverse transcribed using the QuantiTect
Reverse Transcription Kit (Qiagen). The resulting cDNA
samples were diluted 50X and run on the 7900HT Fast
Real-Time PCR System (Applied Biosystems) using Power
SYBR Green PCR Master mix (Life Technologies) and 200
nM primers. Primer sets were designed using Primer3
[44]. The primer sequences for cellular gene targets and
the strand-specific primers for quantifying viral genomic
RNA are listed in Additional file 1: Table S5. For cellular
gene mRNA quantification, relative gene expression in in-
fected samples compared to that in mock-infected samples
was calculated using the 2−ΔΔCT method [45]. The RPL14
gene was selected as an internal control (calibrator) due to
non-significant changes in RPL14 gene expression in
MERS-CoV SA 1- and MERS-CoV Eng 1-infected Calu-3
2B4 cells, as determined by microarray analysis.Functional enrichment analysis
Functional analysis of statistically significant gene ex-
pression changes was performed using Ingenuity Path-
ways Knowledge Base (IPA; Ingenuity Systems). For all
gene set enrichment analyses, a right-tailed Fisher’s exact
test was used to calculate P-values associated with each
biological function and canonical pathway. Upstream
Regulator Analysis in IPA was used to predict regulators
and infer their activation state based on prior knowledge
of expected effects between regulators and their known
target genes according to the Ingenuity Knowledge Base
(IKB). The calculated z-score signifies whether gene ex-
pression changes for known targets of each regulator are
consistent with what is expected from the literature (z > 2,
regulator predicted to be activated, z < -2, regulator pre-
dicted to inhibited). In addition to IPA Upstream Regula-
tor Analysis, we also used EnrichR [46], a collaborative
gene list enrichment tool, to determine possible upstream
regulators via overrepresented transcription factor binding
site motifs [47].
Causal Network Analysis in IPA was used to under-
stand gene expression changes and causal relationships
between genes and networks of upstream regulators in
the experimental dataset. The genes within the causal
network represent nodes and the edge that defines the
biological relationship between two nodes is represented
as an arrow signifying regulation. Dashed arrows repre-
sent indirect relationships and solid arrows represent
direct relationships. All edges are supported by at least
one published reference or from canonical information
stored in IKB.Availability of supporting data
Raw microarray data have been deposited in NCBI’s Gene
Expression Omnibus and are accessible through GEO ac-
cession GSE33267 (icSARS-CoV), GSE45042 (MERS-CoV
SA 1), GSE56677 (MERS-CoV Eng 1), GSE33264 (IFN-α,
and IFN-γ, Calu-3 treatments), and GSE56678 (IL-1α, and
TNF Calu-3 treatments). All data sets and associated
metadata have been submitted to Virus Pathogen Re-
source (ViPR, http://www.viprbrc.org). Study details can
be accessed through the Systems Virology website (http://
www.systemsvirology.org).
Additional files
Additional file 1: Table S5. Primer sequences used for qRT-PCR ana-
lysis of viral genomic RNA expression of MERS-CoV SA1 or MERS-CoV
Eng1 and of gene expression changes in Calu-3 2B4 cells infected with
either MERS-CoV SA1 or MERS-CoV Eng1.
Additional file 2: Table S4. MERS-CoV replication in human airway
Calu-3 2B4 cells.
Additional file 3: Figure S1. MERS-CoV SA 1 and MERS-CoV Eng 1
differentially regulate adherens junction genes facilitating cell-cell adhesion.
Average log2 fold-change expression of 22 DE genes associated with ILK
signaling and 20 DE genes associated with epithelial adherens junction
signaling. Calu-3 cells were infected with MERS-CoV Eng 1 or MERS-CoV
SA 1 (MOI = 5) and total cellular RNA was isolated at 18 and 24 hpi. Red
indicates gene expression was increased relative to the time-matched
mock-infected reference and green indicates gene expression was decreased
relative to the time-matched mock-infected reference. Enrichment analysis of
MERS-CoV contrasting genes from cluster 2 was performed using IPA.
Additional fie 4: Figures S2. Contrasting gene expression profiles of
MERS-CoV-infected Calu-3 cells. Calu-3 cells were infected with MERS-CoV
Eng 1 or MERS-CoV SA 1 (MOI = 5) and total cellular RNA was isolated at
18 and 24 hpi. Relative gene expression was calculated using the 2-ΔΔCt
method [45] and is shown as log2 fold-change of MERS-CoV-infected
samples relative to RPL14 endogenous control. Microarray gene expression
for each cellular target is shown as log2 fold-change of MERS-CoV-infected
samples relative to pooled mock-infected samples for a comparison with
the mRNA expression profiles determined by qRT-PCR.
Additional file 5: R implementation of maximal bipartite graph
matching algorithm to calculate differences in persistence
homology barcodes.
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